These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11173908)

  • 1. Interleukin-18 and Crohn's disease.
    Kanai T; Watanabe M; Okazawa A; Sato T; Hibi T
    Digestion; 2001; 63 Suppl 1():37-42. PubMed ID: 11173908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 18 is a potent proliferative factor for intestinal mucosal lymphocytes in Crohn's disease.
    Kanai T; Watanabe M; Okazawa A; Nakamaru K; Okamoto M; Naganuma M; Ishii H; Ikeda M; Kurimoto M; Hibi T
    Gastroenterology; 2000 Dec; 119(6):1514-23. PubMed ID: 11113073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th1-mediated intestinal inflammation in Crohn's disease may be induced by activation of lamina propria lymphocytes through synergistic stimulation of interleukin-12 and interleukin-18 without T cell receptor engagement.
    Okazawa A; Kanai T; Watanabe M; Yamazaki M; Inoue N; Ikeda M; Kurimoto M; Ishii H; Hibi T
    Am J Gastroenterol; 2002 Dec; 97(12):3108-17. PubMed ID: 12492197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of interleukin 18 in Crohn's disease: evidence from in vitro analysis of human gut inflammatory cells and from experimental colitis models.
    Maerten P; Shen C; Colpaert S; Liu Z; Bullens DA; van Assche G; Penninckx F; Geboes K; Vanham G; Rutgeerts P; Ceuppens JL
    Clin Exp Immunol; 2004 Feb; 135(2):310-7. PubMed ID: 14738461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn's disease.
    Kanai T; Watanabe M; Okazawa A; Sato T; Yamazaki M; Okamoto S; Ishii H; Totsuka T; Iiyama R; Okamoto R; Ikeda M; Kurimoto M; Takeda K; Akira S; Hibi T
    Gastroenterology; 2001 Oct; 121(4):875-88. PubMed ID: 11606501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells.
    Pizarro TT; Michie MH; Bentz M; Woraratanadharm J; Smith MF; Foley E; Moskaluk CA; Bickston SJ; Cominelli F
    J Immunol; 1999 Jun; 162(11):6829-35. PubMed ID: 10352304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
    Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
    J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease.
    Takayama T; Kamada N; Chinen H; Okamoto S; Kitazume MT; Chang J; Matuzaki Y; Suzuki S; Sugita A; Koganei K; Hisamatsu T; Kanai T; Hibi T
    Gastroenterology; 2010 Sep; 139(3):882-92, 892.e1-3. PubMed ID: 20638936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn's disease.
    Matsuoka K; Inoue N; Sato T; Okamoto S; Hisamatsu T; Kishi Y; Sakuraba A; Hitotsumatsu O; Ogata H; Koganei K; Fukushima T; Kanai T; Watanabe M; Ishii H; Hibi T
    Gut; 2004 Sep; 53(9):1303-8. PubMed ID: 15306590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crohn's disease intestinal CD4+ T cells have impaired interleukin-10 production which is not restored by probiotic bacteria.
    Hvas CL; Kelsen J; Agnholt J; Höllsberg P; Tvede M; Møller JK; Dahlerup JF
    Scand J Gastroenterol; 2007 May; 42(5):592-601. PubMed ID: 17454880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Th17-inducing activity of CD14+ CD163 low myeloid cells in intestinal lamina propria of patients with Crohn's disease.
    Ogino T; Nishimura J; Barman S; Kayama H; Uematsu S; Okuzaki D; Osawa H; Haraguchi N; Uemura M; Hata T; Takemasa I; Mizushima T; Yamamoto H; Takeda K; Doki Y; Mori M
    Gastroenterology; 2013 Dec; 145(6):1380-91.e1. PubMed ID: 23993972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defects in mucosal immunity leading to Crohn's disease.
    Cobrin GM; Abreu MT
    Immunol Rev; 2005 Aug; 206():277-95. PubMed ID: 16048555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions.
    Allez M; Tieng V; Nakazawa A; Treton X; Pacault V; Dulphy N; Caillat-Zucman S; Paul P; Gornet JM; Douay C; Ravet S; Tamouza R; Charron D; Lémann M; Mayer L; Toubert A
    Gastroenterology; 2007 Jun; 132(7):2346-58. PubMed ID: 17570210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-bet-Expressing B Cells Are Positively Associated with Crohn's Disease Activity and Support Th1 Inflammation.
    Wang Z; Wang Z; Wang J; Diao Y; Qian X; Zhu N
    DNA Cell Biol; 2016 Oct; 35(10):628-635. PubMed ID: 27348235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the novel Th17 cytokine IL-26 in intestinal inflammation.
    Dambacher J; Beigel F; Zitzmann K; De Toni EN; Göke B; Diepolder HM; Auernhammer CJ; Brand S
    Gut; 2009 Sep; 58(9):1207-17. PubMed ID: 18483078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ activated intestinal T cells expanded in vitro--without addition of antigen--produce IFN-gamma and IL-10 and preserve their function during growth.
    Agnholt J; Kaltoft K
    Exp Clin Immunogenet; 2001; 18(4):213-25. PubMed ID: 11872952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of regulatory B cells in chronic intestinal inflammation: association with pathogenesis of Crohn's disease.
    Oka A; Ishihara S; Mishima Y; Tada Y; Kusunoki R; Fukuba N; Yuki T; Kawashima K; Matsumoto S; Kinoshita Y
    Inflamm Bowel Dis; 2014 Feb; 20(2):315-28. PubMed ID: 24390063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late Crohn's disease patients present an increase in peripheral Th17 cells and cytokine production compared with early patients.
    Veny M; Esteller M; Ricart E; Piqué JM; Panés J; Salas A
    Aliment Pharmacol Ther; 2010 Mar; 31(5):561-72. PubMed ID: 19958311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FoxP3(+)CD4(+)CD25(+) T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease.
    Kelsen J; Agnholt J; Hoffmann HJ; Rømer JL; Hvas CL; Dahlerup JF
    Clin Exp Immunol; 2005 Sep; 141(3):549-57. PubMed ID: 16045746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease.
    Kugathasan S; Saubermann LJ; Smith L; Kou D; Itoh J; Binion DG; Levine AD; Blumberg RS; Fiocchi C
    Gut; 2007 Dec; 56(12):1696-705. PubMed ID: 17682002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.